MedPath

The effect of dydrogesterone and vaginal progestrein in support of artificial reproduction techniques

Not Applicable
Conditions
In vitro fertilization.
Complications of attempted introduction of fertilized ovum following in vitro fertilization
N98.2
Registration Number
IRCT20170205032406N2
Lead Sponsor
Babol University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
210
Inclusion Criteria

20-40 years old
Body Mass Index 18-30 kg/m2
Endometrium Thickness 7-14 mm

Exclusion Criteria

Abnormal prolactin serum level and abnormal thyroid function test
Diminished ovarian reserve ( baseline FSH level >10 IU/mL)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pregnancy. Timepoint: Once a week after embryo transfer into the patient. Method of measurement: The blood hCG test.
Secondary Outcome Measures
NameTimeMethod
Preterm delivery. Timepoint: Every two weeks from the twentieth week of pregnancy. Method of measurement: Patient visit and record uterine contractions.;Amount of live birth. Timepoint: Every two weeks from twenty-eighth week of pregnancy. Method of measurement: Patient visit and record baby's birth.;Abortion. Timepoint: Six weeks after intervention. Method of measurement: Sonography and pregnancy test.
© Copyright 2025. All Rights Reserved by MedPath